Jason Andrade is a Cardiac Electrophysiologist at Vancouver General Hospital in Canada. He is the Director of Electrophysiology at Vancouver General Hospital. He has served as co-chair of the Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines from 2017-2025, and the CCS Device Therapy Guidelines. He has served on the executive for the Canadian Heart Rhythm Society (CHRS) as chair of the Education Committee and chair of the Device Advisory Committee. Over the past 12 years Dr. Andrade has held multiple roles with cardiac services BC, the government agency responsible for delivering cardiac care.
He has authored over 325 scientific publications, predominantly in the domain of atrial fibrillation. His publications can be found in journals such as the New England Journal of Medicine, The Lancet, Circulation, the European Heart Journal, Journal of the American College of Cardiology (JACC), and the Journal of the American Medical Association (JAMA). As a result of these contributions he has been recognized as a “Highly Ranked Scholar”, placing 15 worldwide for Atrial fibrillation and 27 for Catheter Ablation research.
He has received numerous awards including the CIHR-ICRH/CCS Mid-Career Lecturer Award in Cardiovascular Sciences, VMDAS Scientific Achievement award, CHRS George Klein Award, Clinical Faculty Award for Excellence in Research, Donald M Whitelaw Award, Alumni Achievement Award (Ottawa), Robert E. Beamish Award, Michael Smith Foundation for Health Research Clinical Investigator Scholar Award, CCS Bayer Award, Joseph J. Diamond Memorial Prize for Research, Peter J Armanious Award, and was recognized by the Vancouver Whitecaps.